{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:54:48Z","timestamp":1791975288170,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,25]],"date-time":"2020-01-25T00:00:00Z","timestamp":1579910400000},"content-version":"vor","delay-in-days":55,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.repc.2019.06.005","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T17:11:53Z","timestamp":1583773913000},"page":"873-879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Association between copeptin and contrast-induced nephropathy in patients with ST-elevation myocardial infarction"],"prefix":"10.1016","volume":"38","author":[{"given":"Ersin","family":"Yildirim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayca Turer","family":"Cabbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.repc.2019.06.005_bib0210","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/j.ajkd.2004.04.001","article-title":"Prevention of radiocontrast-induced nephropathy","volume":"44","author":"Asif","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.repc.2019.06.005_bib0215","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1161\/01.CIR.0000016043.87291.33","article-title":"Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention","volume":"105","author":"Rihal","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2019.06.005_bib0220","first-page":"442","article-title":"Renal failure after percutaneous coronary intervention is associated with high mortality","volume":"64","author":"Gupta","year":"2005","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.repc.2019.06.005_bib0225","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.amjcard.2004.03.008","article-title":"Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification","volume":"93","author":"Bartholomew","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.repc.2019.06.005_bib0230","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jvs.2011.04.047","article-title":"Contrast-induced nephropathy","volume":"54","author":"Rundback","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.repc.2019.06.005_bib0235","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2174\/15680266113139990088","article-title":"Copeptin as a biomarker in cardiac disease","volume":"13","author":"Giannopoulos","year":"2013","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.repc.2019.06.005_bib0240","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11883-014-0421-5","article-title":"Copeptin-marker of acute myocardial infarction","volume":"16","author":"M\u00f6ckel","year":"2014","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.repc.2019.06.005_bib0245","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/SHK.0b013e318033e5da","article-title":"Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock","volume":"28","author":"Morgenthaler","year":"2007","journal-title":"Shock"},{"key":"10.1016\/j.repc.2019.06.005_bib0250","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/ndt\/gfg277","article-title":"Diabetes-induced albuminuria: role of antidiuretic hormone as revealed by chronic V2 receptor antagonism in rats","volume":"18","author":"Bardoux","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.repc.2019.06.005_bib0255","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.ijcard.2012.12.039","article-title":"Copeptin and cardiovascular disease: a review of a novel neurohormone","volume":"167","author":"Yalta","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.repc.2019.06.005_bib0260","first-page":"1","article-title":"for the KDIGO Work Group Kidney Disease: Improving Global Outcomes. KDIGO clinical practice guideline for acute kidney injury","volume":"2","author":"Kellum","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.repc.2019.06.005_bib0265","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/RLI.0b013e3181d2eed8","article-title":"Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy","volume":"45","author":"Heyman","year":"2010","journal-title":"Invest Radiol"},{"key":"10.1016\/j.repc.2019.06.005_bib0270","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1152\/japplphysiol.01298.2006","article-title":"Hypoxia-induced reactive oxygen species formation in skeletal muscle","volume":"102","author":"Clanton","year":"2007","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.repc.2019.06.005_bib0275","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000051036","article-title":"Vascular biology of the isoprostanes","volume":"38","author":"Cracowski","year":"2001","journal-title":"J Vasc Res"},{"key":"10.1016\/j.repc.2019.06.005_bib0280","doi-asserted-by":"crossref","first-page":"R335","DOI":"10.1152\/ajpregu.00605.2001","article-title":"Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature","volume":"282","author":"Schnackemberg","year":"2002","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.repc.2019.06.005_bib0285","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1067\/mhj.2002.122118","article-title":"Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy","volume":"143","author":"Tumlin","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.repc.2019.06.005_bib0290","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5603\/KP.a2017.0177","article-title":"CHA2DS2-VASc score predicts contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction, who have undergone primary percutaneous coronary intervention","volume":"76","author":"Cicek","year":"2018","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.repc.2019.06.005_bib0295","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa021833","article-title":"Nephrotoxic effects in high-risk patients undergoing angiography","volume":"348","author":"Aspelin","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repc.2019.06.005_bib0300","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000051036","article-title":"Vascular biology of the isoprostanes","volume":"38","author":"Cracowski","year":"2001","journal-title":"J Vasc Res"},{"key":"10.1016\/j.repc.2019.06.005_bib0305","first-page":"1393","article-title":"A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation","volume":"44","author":"Mehran","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.repc.2019.06.005_bib0310","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1067\/mhj.2002.122118","article-title":"Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy","volume":"143","author":"Tumlin","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.repc.2019.06.005_bib0315","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1148\/radiol.2433061411","article-title":"Risk of iodinated contrast material-induced nephropathy with intravenous administration","volume":"243","author":"Katzberg","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.repc.2019.06.005_bib0320","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1540-8183.2002.tb01067.x","article-title":"Determinants of serum creatinine trajectory in acute contrast nephropathy","volume":"15","author":"Guitterez","year":"2002","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.repc.2019.06.005_bib0325","first-page":"335","article-title":"Analysis of biomarkers for risk of acute kidney injury after primary angioplasty for acute ST-segment elevation myocardial infarction: results of the HORIZONS-AMI trial","volume":"85","author":"Guerchicoff","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.repc.2019.06.005_bib0330","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2019.06.005_bib0335","doi-asserted-by":"crossref","first-page":"e1160127","DOI":"10.1371\/journal.pone.0127116","article-title":"Changes in plasma copeptin levels during hemodialysis: are the physiological stimuli active in hemodialysis patients?","volume":"10","author":"Ettema","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.repc.2019.06.005_bib0340","first-page":"6","article-title":"Serum copeptin as a new biomarker in the early diagnosis of decline in renal function of type 2 diabetes mellitus patients","author":"Hu","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.repc.2019.06.005_bib0345","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jdiacomp.2015.07.006","article-title":"Association between copeptin and declining glomerular filtration rate in people with newly diagnosed diabetes. The Skaraborg Diabetes Register","volume":"29","author":"Pikkemaat","year":"2015","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.repc.2019.06.005_bib0350","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000439061","article-title":"Plasma copeptin and decline in renal function in a cohort from the community: the prospective D.E.S.I.R study","volume":"42","author":"Roussel","year":"2015","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.repc.2019.06.005_bib0355","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000447522","article-title":"Increased levels of copeptin, a surrogate marker of arginine vasopressin, are associated with an increased risk of chronic kidney disease in a general population","volume":"44","author":"Tasevska","year":"2016","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.repc.2019.06.005_bib0360","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ijcard.2016.07.058","article-title":"Elevated copeptin is a prognostic factor for mortality even in patients with renal dysfunction","volume":"221","author":"Engelbertz","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.repc.2019.06.005_bib0365","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.hlc.2014.10.008","article-title":"Copeptin (C-terminal pro arginine-vasopressin) is an independent long-term prognostic marker in heart failure with reduced ejection fraction","volume":"24","author":"Pozsonyi","year":"2015","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.repc.2019.06.005_bib0370","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.acc.2015.10.006","article-title":"Copeptin in heart failure","volume":"73","author":"Balling","year":"2016","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.repc.2019.06.005_bib0375","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3349\/ymj.2015.56.4.976","article-title":"Copeptin in hemodialysis patients with left ventricular dysfunction","volume":"56","author":"Kim","year":"2015","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.repc.2019.06.005_bib0380","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jdiacomp.2016.04.012","article-title":"Elevated copeptin is associated with atherosclerosis and diabetic kidney disease in adults with type 1 diabetes","volume":"30","author":"Bjornstad","year":"2016","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.repc.2019.06.005_bib0385","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijcard.2011.12.105","article-title":"Copeptin as a prognostic factor for major adverse cardiovascular events in patients with coronary artery disease","volume":"162","author":"Von Haehling","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.repc.2019.06.005_bib0390","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1097\/HJH.0000000000001106","article-title":"Copeptin is increased in resistant hypertension","volume":"34","author":"Mendes","year":"2016","journal-title":"Hypertens"},{"key":"10.1016\/j.repc.2019.06.005_bib0395","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/heartjnl-2013-303975","article-title":"Association of copeptin with myocardial infarct size and myocardial function after ST segment elevation myocardial infarction","volume":"99","author":"Reinstadler","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.repc.2019.06.005_bib0400","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1373\/clinchem.2015.240580","article-title":"Temporal release pattern of copeptin and troponin T in patients with suspected acute coronary syndrome and spontaneous acute myocardial infarction","volume":"61","author":"Slagman","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/j.repc.2019.06.005_bib0405","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehu178","article-title":"Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study","volume":"36","author":"M\u00f6ckel","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2019.06.005_bib0410","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1741-7015-12-80","article-title":"Risk stratification in emergency patients by copeptin","volume":"12","author":"Iversen","year":"2014","journal-title":"BMC Med"}],"container-title":["Revista Portuguesa de Cardiologia"],"original-title":[],"language":"pt","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255120300330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255120300330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:08:11Z","timestamp":1760108891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0870255120300330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0870255120300330"],"URL":"https:\/\/doi.org\/10.1016\/j.repc.2019.06.005","relation":{},"ISSN":["0870-2551"],"issn-type":[{"value":"0870-2551","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between copeptin and contrast-induced nephropathy in patients with ST-elevation myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2019.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}